Alligator Bioscience AB Share Price London S.E.
Equities
0RK9
SE0000767188
Biotechnology & Medical Research
Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
1.271 SEK | -49.33% | +123.96% | +303.28% |
Sales 2024 * | 261M 24.97M 2.08B | Sales 2025 * | 122M 11.7M 976M | Capitalization | 957M 91.48M 7.63B |
---|---|---|---|---|---|
Net income 2024 * | -6M -574K -47.86M | Net income 2025 * | -89M -8.51M -710M | EV / Sales 2024 * | 2.15 x |
Net cash position 2024 * | 395M 37.72M 3.15B | Net cash position 2025 * | - 0 0 | EV / Sales 2025 * | 7.82 x |
P/E ratio 2024 * |
-2.77
x | P/E ratio 2025 * |
-12.6
x | Employees | 55 |
Yield 2024 * |
-
| Yield 2025 * |
-
| Free-Float | 59.28% |
Latest transcript on Alligator Bioscience AB
1 day | -49.33% | ||
1 week | +123.96% | ||
Current month | +123.96% | ||
1 month | +123.96% | ||
3 months | +123.96% | ||
6 months | +303.28% | ||
Current year | +303.28% |
Managers | Title | Age | Since |
---|---|---|---|
Søren Bregenholt
CEO | Chief Executive Officer | 53 | 01/21/01 |
Marie Svensson
DFI | Director of Finance/CFO | 60 | 01/20/01 |
Chief Tech/Sci/R&D Officer | 56 | 01/22/01 |
Members of the board | Title | Age | Since |
---|---|---|---|
Chairman | 70 | 01/17/01 | |
Staffan Encrantz
BRD | Director/Board Member | 72 | 09/22/09 |
Director/Board Member | 62 | 01/21/01 |
Date | Price | Change | Volume |
---|---|---|---|
17/21/17 | 2.508 | -66.28% | 1 040 000 |
Delayed Quote London S.E., November 17, 2021 at 09:22 pm IST
More quotesEPS Revisions
Annual profits - Rate of surprise
1st Jan change | Capi. | |
---|---|---|
+34.38% | 52.85B | |
-7.52% | 38.87B | |
+35.31% | 38.24B | |
-10.77% | 26.79B | |
+11.68% | 26.16B | |
-18.43% | 19.9B | |
+36.15% | 13.18B | |
+28.99% | 12.24B | |
-2.95% | 11.79B |
- Stock Market
- Equities
- ATORX Stock
- 0RK9 Stock